$CJMB

CALLAN JMB INC. (CJMB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 Settlement, Waiver and Release Agreement This Settlement, Waiver and Release Agreement (“ Agreement ” or “ Settlement Agreement ”) is made and entered into as of June 5, 2026 (“ Effective Date ”) by and between CALLAN JMB Inc., a Nevada C

Original reporting
Published Jun 11, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CJMB
Neutral
medium confidence
Mentioned
$CJMB
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CJMBNeutralLow
01

Why it matters

The settlement specifies $125,000 total severance in three monthly installments, accrued unused vacation payout, and that 212,500 vested stock options remain outstanding/exercisable through their original 10-year term (no shortened post-termination exercise period).

02

Market read

This is a defined executive departure/compensation disclosure; it may move the stock modestly on governance sentiment but lacks new financial or strategic guidance.

03

What to watch

Traders may want to check whether the resignation triggers any additional disclosures (e.g., new officer appointments, board committee changes) in subsequent filings beyond Item 5.02.

Relevance 6/10Novelty 5/10Timing: Filed June 11, 2026 (after-hours/SEC filing window)

Background

The 8-K (Item 5.02) documents termination of an employment agreement and voluntary resignation of an executive who also served on the board, with mutual releases and defined severance/covenant handling.

Company-level read

Ticker impact

$CJMBNeutralMedium confidence
Context

CJMB discloses an executive/board resignation tied to a settlement agreement, including a $125,000 lump-sum severance paid in three installments and continued exercisability of vested options.

Expected impact

Low-to-moderate downside risk from governance/leadership uncertainty; otherwise limited fundamental read-through.

Evidence & confidence

The filing is an Item 5.02 executive departure/compensation arrangement with no stated operational or financial guidance change; the only quantified items are severance and option exercisability mechanics.

Market effects

Minimal—this is company-specific governance/HR news, not a sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even without operational impact, the continued exercisability of vested options may reduce immediate dilution/overhang concerns versus a scenario where options were shortened or forfeited.

Key entities

  • CALLAN JMB Inc.

    Nevada corporation filing the 8-K; common stock trades on Nasdaq Capital Market under CJMB.

  • Eric Kash

    Executive Vice-President and board member who resigns; receives settlement/severance and vacation payout under the agreement.

Related articles

$CJMBMedAI 8/10

Callan JMB (CJMB) Stock Rallies 50% After Hours: Here's Why it is Trending - Callan Jmb (NASDAQ:CJMB)

Callan JMB Inc. (NASDAQ:CJMB) shares rose about 49.8% to $1.29 after hours after the company said it signed a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem. Callan will provide logistics and regulatory support and receive 21% of qualifying gross revenue. Management projected annual gross revenues near $500 million, about $105 million for the company. The stock also faces a Nasdaq $1 bid compliance deadline.

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.